This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Feb 23, 2025 0
Feb 23, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 27, 2025 0
Feb 27, 2025 0
Feb 27, 2025 0
Feb 27, 2025 0
Feb 26, 2025 0
Or register with email
Feb 9, 2025 0
Product Management Service (PMS) webinar on Product User Interface (PUI) edit fu...
Feb 9, 2025 0
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of ...
Feb 9, 2025 0
Questions and answers clinic on Product Management Service (PMS) Product User In...
Feb 9, 2025 0
List of medicines currently in PRIME scheme
Feb 9, 2025 0
Human medicines European public assessment report (EPAR): Kesimpta, ofatumumab, ...
Feb 9, 2025 0
Human medicines European public assessment report (EPAR): Datroway, datopotamab ...
Feb 9, 2025 0
EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9...
Feb 9, 2025 0
Human medicines European public assessment report (EPAR): Stivarga, regorafenib,...
Feb 9, 2025 0
Feb 10, 2025 0
Feb 11, 2025 0
Feb 9, 2025 0
Feb 21, 2025 0
Feb 13, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.